Methyl trans 5-chloro-2-(phenylsulfonylamino)cinnamate → Methyl[5-chloro-2-(4-isopropylpyridine-2-carbonyl)-1h-indol-3-yl]acetate
Reaktionsgleichung
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([NH:14]S(C2C=CC=CC=2)(=O)=O)=[C:6]([CH:13]=1)/[CH:7]=[CH:8]/[C:9]([O:11][CH3:12])=[O:10].Br[CH2:25][C:26]([C:28]1[CH:33]=[C:32]([CH:34]([CH3:36])[CH3:35])[CH:31]=[CH:30][N:29]=1)=[O:27]>>[CH3:12][O:11][C:9](=[O:10])[CH2:8][C:7]1[C:6]2[C:5](=[CH:4][CH:3]=[C:2]([Cl:1])[CH:13]=2)[NH:14][C:25]=1[C:26]([C:28]1[CH:33]=[C:32]([CH:34]([CH3:36])[CH3:35])[CH:31]=[CH:30][N:29]=1)=[O:27]Komponenten
3
Versuchsvorschrift
The title compound was prepared according to the procedure described in Example 57 from methyl trans-5-chloro-2-(penylsulfonylamino)cinnamate (Example 36, step 3) and 2-bromoacetyl-4-isopropylpyridine (Preparation is described in Example 61).
Quellen und Nachweise
- ORD-Eintrag
- ord-fd5d9a815a064bf8913f4e7c71c58093
- Quelldatensatz
- uspto-grants-2003_08
- Patentnummer
- US06608070B1
Notizen zur Reaktion
Wird geladen…